International Multispeciality Journal of Health - United Kingdom British Medical Research | Clinical Excellence | Pharmaceutical Innovation | NHS Research
Top Medical Journal in the United Kingdom
ISSN: 2395-6291 | R Impact Factor: 3.83 | DOI: 10.25125/medical-journal | Indexed in CrossRef, Google Scholar, PubMed Central (in progress), WorldCat
Medical Research Landscape in the United Kingdom: Key Statistics
Medical Research Publications
Annually
Pharmaceutical Research
Centers
Medical Schools
Nationwide
Annual Health Research
Investment
Source: UK Research and Innovation (UKRI), National Institute for Health and Care Research (NIHR), Medical Research Council (MRC), 2024 Research Report
Medical Research Landscape in the United Kingdom
The United Kingdom, with a population of over 67 million, stands as a global leader in medical and pharmaceutical research. The country boasts a rich scientific heritage, with contributions from Nobel laureates such as Alexander Fleming (penicillin), Francis Crick (DNA structure), and Sir Peter Ratcliffe (oxygen sensing). Today, the UK continues this tradition through world-class institutions like the Medical Research Council (MRC), the National Institute for Health and Care Research (NIHR), and the Wellcome Trust. Through initiatives like the UK Research and Innovation (UKRI) and the Life Sciences Vision, the UK is making unprecedented investments in biomedical research, particularly in areas such as genomics, precision medicine, and clinical trials.
Genomics & Precision Medicine
The UK is a world leader in genomics, with the 100,000 Genomes Project and the UK Biobank providing unparalleled resources for genetic research. The country's commitment to precision medicine is transforming healthcare delivery.
Clinical Trials & Translational Research
The UK's National Health Service (NHS) provides an exceptional platform for clinical research, with the NIHR Clinical Research Network supporting studies across the country, making the UK a premier destination for clinical trials.
About IMJ Health: Your Partner in Medical Research
The International Multispeciality Journal of Health (IMJ Health) is a prestigious, peer-reviewed, open-access journal dedicated to advancing medical and pharmaceutical sciences globally. We provide UK researchers, clinicians, and healthcare professionals with a respected platform to publish their groundbreaking findings and contribute to the global medical community.
With our commitment to quality, speed, and visibility, IMJ Health ensures that research from the United Kingdom reaches a worldwide audience, fostering collaboration and knowledge exchange that addresses both local and global health challenges.
Open Access
Global VisibilityRapid Review
4-6 weeksGlobal Indexing
PubMed Central (in progress)Top UK Institutions Publishing in IMJ Health
Researchers from these leading UK institutions have published their work in IMJ Health:
- University of Oxford
- University of Cambridge
- Imperial College London
- University College London (UCL)
- King's College London (KCL)
- University of Edinburgh
- University of Manchester
- University of Glasgow
- Francis Crick Institute
United Kingdom's Medical Research Priorities
UK Research and Innovation (UKRI), the Medical Research Council (MRC), and the National Institute for Health and Care Research (NIHR) have identified key priority areas:
Genomics & Precision Medicine
- UK Biobank (500,000 participants)
- 100,000 Genomes Project
- Genomics England and NHS Genomic Medicine Service
- Rare diseases research
- Pharmacogenomics and personalized treatment
Neuroscience & Mental Health
- Dementia research (UK DRI)
- Alzheimer's and neurodegenerative diseases
- Mental health research (Maudsley Hospital)
- Parkinson's disease and multiple sclerosis
- Neurodevelopmental disorders
Pharmaceutical Innovation & Clinical Trials
- NIHR Clinical Research Network
- Early-phase clinical trials
- Advanced therapies (cell and gene)
- Vaccine development (Oxford-AstraZeneca)
- Antimicrobial resistance (AMR)
Cardiovascular & Metabolic Disease
- British Heart Foundation (BHF) research
- Diabetes UK research programs
- Atherosclerosis and coronary disease
- Hypertension and stroke prevention
- Obesity and metabolic syndrome
Cancer Research
- Cancer Research UK (CRUK)
- The Institute of Cancer Research (ICR)
- Immuno-oncology and CAR-T therapy
- Early detection and screening
- Pediatric oncology
Respiratory & Infectious Diseases
- COVID-19 and emerging infections
- Tuberculosis and HIV research
- Asthma and COPD research
- Antimicrobial resistance (AMR)
- Vaccine development and immunology
Traditional British Medicine & Herbalism
The United Kingdom has a rich heritage of traditional medicine, including British herbalism (herbal medicine), with the Royal College of Physicians' Herbal Garden established in 1673. Traditional British remedies include elderflower, chamomile, and nettle, with the National Institute of Medical Herbalists (NIMH) established in 1864. The country's diverse flora, including the Scottish Highlands, Welsh valleys, and English countryside, offers exceptional opportunities for natural product research.
British Herbalism
Elderflower (Sambucus nigra)
Immune support, antiviral, respiratory health | Traditional cold remedy
Chamomile (Matricaria chamomilla)
Calming, digestive health, anti-inflammatory | Traditional British tea
Nettle (Urtica dioica)
Anti-inflammatory, arthritis relief, nutritional | Traditional spring tonic
Lavender (Lavandula angustifolia)
Calming, sleep aid, anxiolytic | English lavender heritage
Rose Hip (Rosa canina)
Vitamin C rich, antioxidant, immune support | Traditional rosehip syrup
Hawthorn (Crataegus monogyna)
Cardiovascular health, heart tonic | Traditional heart remedy
Leading Medical Research Institutions in the United Kingdom
- Medical Research Council (MRC)
- National Institute for Health and Care Research (NIHR)
- Wellcome Trust (Sanger Institute)
- Francis Crick Institute (London)
- UK Biobank (Manchester)
- Cancer Research UK (CRUK) Institutes
- British Heart Foundation (BHF) Research Centers
- Dementia Research Institute (UK DRI)
- Rosalind Franklin Institute
- Medicines and Healthcare products Regulatory Agency (MHRA)
Why UK Researchers Choose IMJ Health
Rigorous Peer Review
Double-blind peer review ensures quality, reliability, and credibility of published research, enhancing your academic reputation.
High Visibility & Impact
Indexed in Google Scholar, CrossRef, WorldCat, and Index Copernicus, with PubMed Central indexing in progress, ensuring global visibility.
Rapid Publication
Efficient editorial workflow with average publication time of 4-6 weeks from submission to online publication.
CrossRef DOI Registration
Every published article receives a unique DOI, ensuring permanent accessibility and citation tracking.
Frequently Asked Questions
Comprehensive FAQ for UK Authors
Find answers about submission process, peer review, publication fees, PubMed Central indexing status, and more for UK medical researchers.
The average time from submission to publication is 4-6 weeks for articles from UK researchers. Our streamlined peer review process ensures rapid publication without compromising quality.
Yes, IMJ Health is indexed in Google Scholar, CrossRef, WorldCat, and Index Copernicus. We are actively pursuing indexing in PubMed Central (PMC) to meet the high standards expected by UK researchers and institutions, including the NIHR and MRC.
Current Indexing Status:
- Google Scholar
- CrossRef (DOI Member)
- WorldCat
- Index Copernicus
- PubMed Central (PMC) - Application in Process
Absolutely! IMJ Health welcomes research funded by UK Research and Innovation (UKRI), the Medical Research Council (MRC), the National Institute for Health and Care Research (NIHR), and other UK funding agencies. We support open access publishing in compliance with UKRI's open access policy.
- Genomics and precision medicine (UK Biobank, 100,000 Genomes)
- Clinical trials and translational research (NIHR)
- Neuroscience and dementia research (UK DRI)
- Cancer research (Cancer Research UK)
- Cardiovascular research (British Heart Foundation)
- Infectious diseases and vaccine development
Publication fees vary based on article type and length. We offer competitive rates for researchers from UK institutions. Many funding agencies, including UKRI, MRC, and NIHR, allow publication fees as part of research grants, in compliance with UKRI's open access policy.
Academic Faculty
$100 (USD)
Approx. £ 80
Students/Scholars
$80 (USD)
Approx. £ 64
You can submit your article online via the Submit Article Link on the journal's homepage. You can also email your submission to info@imjhealth.org or info.imjh@gmail.com. Electronic submission helps reduce processing time and speeds up publication.
Yes, IMJ Health is an open-access journal, and all published articles are freely available immediately upon publication. This complies with UKRI's open access policy, which requires that research funded by UKRI must be made freely available at the time of publication.
You can contact our editorial office through multiple channels:
WhatsApp:
+44 12 3456 7890 (for UK authors)
Response within 24 hours on business days
Join the United Kingdom's Leading Medical Researchers
Share your research with the global medical community. IMJ Health is your trusted partner in advancing medical science from the UK to the world.
Submit Your Research
Online Submission
https://imjhealth.org/submit-article
Fast, secure, and user-friendly submission portal